In partnership with the Department of Internal Medicine the University of Utah School of Medicine Alumni Association offers a morning of CME presentations. CME credit available.
SSLIM’s mission invests in tomorrow’s leaders today by supporting recruiting, faculty support, and scholarship. The morning will consist of a series of presentations, including a morning keynote.
KeynotePlatelets in Sepsis: Genetic and Functional Alterations Impact Host Responses - Matthew Rondina, MD
- The Awesome Power of Genetics: What Flies Can Teach Us About Human Physiology - Aylin Rodan, MD, PhD
- Caring and Curing: Patient/Physician Relationships - Linda Leckman, MD
- Quality Drives Costs: Why Pay for Value Is In Your Future - Brent James, MD, MStat
Matthew Rondina, MD
Associate Professor of Internal Medicine, Division of General Internal Medicine
Investigator, George E. Wahlen VAMC Geriatric Research, Education, and Clinical Care Center
Director, Utah CCTS Precision Medicine Foundation
Director, University of Utah Molecular Medicine Program
Dr. Matthew Rondina has been a faculty member of the University of Utah Department of Medicine since 2006, where he first served as Chief Medical Resident. He subsequently completed a Master’s of Science in Clinical Investigation (MSCI) degree through the University of Utah Center for Clinical and Translational Science (CCTS). His clinical practice is focused on the prevention and treatment of thrombotic disorders, including deep vein thrombosis, pulmonary embolism, stroke, and peripheral vascular disease. Dr. Rondina teaches students and residents about these disorders and speaks internationally on these topics.
Dr. Rondina’s research program, housed within the Eccles Institute of Human Genetics, focuses on understanding the cellular and molecular pathways regulating thrombo-inflammation. He has been continuously NIH-funded for more than a decade and has published more than 125 peer-reviewed manuscripts. He holds three RO1s and a VA Merit as a Principal Investigator, in addition to other grants where he serves as a Co-Investigator. He is the recipient of numerous awards, include an American Society of Clinical Investigation (ASCI) Young Physician-Scientist Award and the University of Utah School of Medicine Alumni Association Golden Anniversary Prize for Distinguished Clinical Investigation.
Dr. Rondina serves as Director of the University of Utah Molecular Medicine Program and Director of the Utah CCTS Precision Medicine Foundation. He also serves as a regular mentor for the T35 Medical Student Research Program at the University of Utah.
Aylin Rodan, MD, PhD
Assistant Professor of Internal Medicine
Dr. Aylin Rodan received her undergraduate degree in Biology from Yale University, where she first developed her interest in science, medicine and the relationship of these two disciplines. She then completed MD/PhD training in the Medical Scientist Training Program at the University of California San Francisco. Her Ph.D. research focused on use of the fly, Drosophila melanogaster, to understand the molecular and cellular mechanisms mediating behavioral changes to alcohol. She then completed Internal Medicine residency at UCSF, followed by clinical nephrology subspecialty training and postdoctoral fellowships in renal physiology and Drosophila genetics at the University of Texas Southwestern Medical Center, where she remained on faculty for five years prior to coming to the University of Utah in 2016 to join the Division of Nephrology and Hypertension in the Department of Internal Medicine.
Since 2011, Dr. Rodan’s research has been supported by the National Institutes of Health, American Heart Association, and the American Society of Nephrology, and she is currently supported by an R01 from the National Institutes of Health and a Collaborative Sciences Award from the American Heart Association. The primary focus of Dr. Rodan’s research is understanding signaling cascades regulating ion transport processes, particularly in the kidney, but also in other settings such as stroke, circadian rhythm and osmoregulation. Dr. Rodan uses genetic techniques in Drosophila melanogaster to understand the molecular basis of ion transport physiology relevant to human physiology and pathophysiology, including electrolyte disorders and high blood pressure.
Dr. Rodan teaches high school, undergraduate, medical and graduate students, and medical residents, and nephrology fellows, on the wards, in the lab, and in the classroom, with a passion for the teaching of renal physiology underlying human disorders. She serves on the MD/PhD Admissions Committee and the Institutional Review Board at the University of Utah, is active on committees of the American Physiological Society and the American Society of Nephrology, and serves on the Board of Directors of the American Physician Scientists Association, a trainee-run organization dedicated to the support and development of physician-scientist trainees.
Linda Leckman, MD
Past VP, Intermountain Healthcare
CEO of Intermountain Medical Group
Dr. Linda Leckman graduated from the University of New Mexico Medical School and completed her residency in general surgery at the University of Utah as the first woman to complete that program. She then practiced general surgery in the Salt Lake Valley at Alta View and Cottonwood Hospitals and served in various hospital and Utah Medical Association leadership roles.
In 1996 Dr. Leckman became Vice President of Intermountain Healthcare in her role as CEO of the Intermountain Medical Group. That group eventually grew to 1200 employed physicians in over 180 clinics. Coordination of care, integration of behavioral services into primary care and measurable quality initiatives were a focus.
In 2011 Dr. Leckman was recognized nationally as one of the Top 25 Women in Healthcare. Her business leadership was noted in 2013 by the Salt Lake Chamber of Commerce when she was awarded their Athena Leadership Award. For over ten years Linda taught a course on clinician-patient communication to the clinicians of the Medical Group.
Brent James, MD
Clinical Professor, Department of Medicine, Stanford University School of Medicine
Dr. Brent James, recently retired Chief Quality Officer and Executive Director of the Institute for Health Care Delivery at Intermountain Healthcare is world renowned for his influence on and work to improve the quality of patient care while reducing the cost of treatment. Dr. James currently holds faculty appointments at the University of Utah School of Medicine, T.H. Chan Harvard School of Public Health and the Stanford University School of Medicine. As leader of Intermountain Healthcare’s Advanced Training Program in Clinical Practice Improvement, he has trained over 5,000 senior physician, nursing and administrative executives drawn from around the world. Dr. James also organized more than 50 sister training programs currently running in ten different countries.
Dr. James has joined the faculty of the Master of Healthcare Administration (MHA) program at the David Eccles School of Business at the University of Utah. Dr. James will teach courses in the MHA program as well as in the new Certificate in Quality Management and Leadership. He is a member of the National Academy of Medicine. He received the prestigious Deming Cup for Quality Productivity and Competitiveness from Columbia University, the C. Jackson Grayson Medal as a Distinguished Quality Pioneer from the American Quality and Productivity Center, and a long list of other national clinical quality awards. In 2009, Dr. James was featured in the New York Times Magazine for his ground breaking work in clinical quality improvement. For 8 of first the 9 years it existed, he was named among Modern Physician’s “50 Most Influential Physician Executives in Healthcare.” He was also named among the Modern Healthcare’s “100 Most Powerful People in Healthcare” for more than 5 years as well as the “25 Top Clinical Informaticists”.
Dr. James holds Bachelor of Science degrees in both computer science and medical biology, a Master of Statistics degree, as well as a Medical Doctorate with residency training in general surgery and oncology, all earned at the University of Utah. In addition, Dr. James completed a fellowship in biostatistics at the Harvard School of Public Health.